CNQX (Synonyms: 6cyano7Nitroquinoxaline2,3dione, FG 9065) |
| Catalog No.GC11799 |
CNQX (FG9065) est un antagoniste puissant et compétitif des récepteurs AMPA/kainate avec des IC50 de 0,3 μM et 1,5 μM, respectivement.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 115066-14-3
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
CNQX is an effective competitive antagonist of AMPA/kainate receptors, with IC50 values of 0.3µM and 1.5µM, respectively[1]. CNQX is a non-NMDA receptor antagonist[2].
In vitro, CNQX (1µM) reduces the frequency of light-induced peak potentials in retinal ganglion cells by 28%±22% and also induces voltage- and magnesium-dependent delayed spike firing[2]. CNQX (0-100 mM; 20-24 h) exhibits dose-dependent toxicity in mixed mouse cortical cells, with neuronal damage effects[3]. CNQX (20 µM) reversibly depolarizes the membrane potential of TRN neurons, inducing smaller depolarizations in thalamic relay neurons in VB[4].
In vivo, CNQX (0.5 µg; i.c.v.) can block hippocampal CA3 pyramidal cell death induced by kainic acid in ICR mice, partially attenuate the increase of p-ERK and the decrease of p-CREB, and inhibit the expression of phosphorylated ERK protein[5]. Bilateral infusion of CNQX (0.5 or 1.25µg) into the amygdala or dorsal hippocampus of rats can block the expression of startle reflex[6].
References:
[1]TAGE HONORÉ, STEVE N. DAVIES, JØRGEN DREJER, et al. Quinoxalinediones: Potent Competitive Non-NMDA Glutamate Receptor Antagonists[J]. SCIENCE.1988(241):701-703.
[2] Jeffrey S. Diamond, David R. Copenhagen. The contribution of NMDA and Non-NMDA receptors to the light-evoked input-output characteristics of retinal ganglion cells[J]. Cell Press. October, 1993:725-738.
[3]Uliasz T F , Hewett S J . A microtiter trypan blue absorbance assay for the quantitative determination of excitotoxic neuronal injury in cell culture[J]. Journal of Neuroscience Methods, 2000, 100(1-2):157-163.
[4]Sang Hun Lee,G. Govindaiah,and Charles L. Cox. Selective Excitatory Actions of DNQX and CNQX in Rat Thalamic Neurons[J].Journal of Neurophysiology, 2010(4):103.
[5]Lee J K , Choi S S , Lee H K ,et al.Effects of MK-801 and CNQX on various neurotoxic responses induced by kainic acid in mice.[J]. Molecules & Cells, 2002, 14(3):339-347.
[6]Kim M, Campeau S, Falls W A, et al. Infusion of the non-NMDA receptor antagonist CNQX into the amygdala blocks the expression of fear-potentiated startle. Behav Neural Biol, 1993, 59(1): 5-8.
Average Rating: 5 (Based on Reviews and 9 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *